SHAHBAZ KHAN: Open Payments
NPI 1164597167 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $64 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Braeburn Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII, BRIXADI, TRINTELLIX.
Industry payments across DC — which companies pay providers there.
